Sebastian Lucas1. 1. Department of Histopathology, King's College London School of Medicine, St Thomas' Hospital, London, UK. Sebastian.lucas@kcl.ac.uk
Abstract
PURPOSE OF REVIEW: Compared with vast literature on the clinical, imaging, and in-vivo microbiology aspects of HIV disease, there is less on biopsy pathology and even less on autopsy data. This review focuses on some current clinico-pathological issues, with indications of where there is less certainty than we would like. RECENT FINDINGS: The most important change in causes of death in HIV disease, since the advent of highly active antiretroviral therapy (HAART), is the reduction of classical AIDS-defining opportunistic diseases, with the compensating increase in background comorbidities related to lifestyle, infections including the hepatitis viruses and HHV8, ageing, drug toxicity and immune reconstitution inflammatory syndrome phenomena. In low-income countries, HIV contributes significantly to maternal mortality. SUMMARY: To understand HIV disease better and manage future patients better, we need more tissue clinico-pathological correlation, including quality biopsy and autopsy evaluations.
PURPOSE OF REVIEW: Compared with vast literature on the clinical, imaging, and in-vivo microbiology aspects of HIV disease, there is less on biopsy pathology and even less on autopsy data. This review focuses on some current clinico-pathological issues, with indications of where there is less certainty than we would like. RECENT FINDINGS: The most important change in causes of death in HIV disease, since the advent of highly active antiretroviral therapy (HAART), is the reduction of classical AIDS-defining opportunistic diseases, with the compensating increase in background comorbidities related to lifestyle, infections including the hepatitis viruses and HHV8, ageing, drug toxicity and immune reconstitution inflammatory syndrome phenomena. In low-income countries, HIV contributes significantly to maternal mortality. SUMMARY: To understand HIV disease better and manage future patients better, we need more tissue clinico-pathological correlation, including quality biopsy and autopsy evaluations.
Authors: Charlene S Dezzutti; Sarah Yandura; Lin Wang; Bernard Moncla; Elizabeth A Teeple; Brid Devlin; Jeremy Nuttall; Elizabeth R Brown; Lisa C Rohan Journal: Pharm Res Date: 2015-06-16 Impact factor: 4.200
Authors: Nikoloz Chkhartishvili; Lali Sharvadze; Otar Chokoshvili; Natalia Bolokadze; Nino Rukhadze; Russell R Kempker; Amiran Gamkrelidze; Jack A DeHovitz; Carlos Del Rio; Tengiz Tsertsvadze Journal: AIDS Res Hum Retroviruses Date: 2014-02-24 Impact factor: 2.205
Authors: Charlene S Dezzutti; Cory Shetler; Alamelu Mahalingam; Shweta R Ugaonkar; Garry Gwozdz; Karen W Buckheit; Robert W Buckheit Journal: Antiviral Res Date: 2012-08-23 Impact factor: 5.970
Authors: Janice J Endsley; Matthew B Huante; Kubra F Naqvi; Benjamin B Gelman; Mark A Endsley Journal: Retrovirology Date: 2021-06-16 Impact factor: 4.602
Authors: Emily B Wong; Tanvier Omar; Gosetsemang J Setlhako; Regina Osih; Charles Feldman; David M Murdoch; Neil A Martinson; David R Bangsberg; W D F Venter Journal: PLoS One Date: 2012-10-16 Impact factor: 3.240